▁it ▁had ▁exerc ised ▁its ▁option ▁to ▁ac quire ▁Cry o V asc ular ▁Systems , ▁Inc . ▁and ▁its ▁propriet ary ▁ang iop last y ▁device ▁to ▁treat ▁a ther os cler otic ▁disease ▁of ▁the ▁legs ▁and ▁other ▁peri pher al ▁ar ter ies . ▁In ▁June ▁Boston ▁Scient ific ▁announced ▁that ▁its ▁wh olly ▁owned ▁subs idi ary , ▁N emo ▁I ▁Ac quisition , ▁Inc ., ▁had ▁successfully ▁acquired ▁Rub icon ▁Medical ▁Corporation , ▁with ▁Rub icon ▁became ▁a ▁wh olly ▁owned ▁subs idi ary ▁of ▁Boston ▁Scient ific . ▁ ▁Gu id ant ▁mer ger ▁In ▁January ▁ 2 0 0 6 , ▁the ▁company ▁announced ▁an ▁offer ▁for ▁Gu id ant ▁of ▁$ 7 2 ▁per ▁share ▁or ▁$ 2 5 ▁billion , ▁this ▁offer ▁was ▁however , ▁rejected . ▁On ▁April ▁ 2 1 , ▁the ▁company ▁acquired ▁long time ▁compet itor ▁Gu id ant ▁for ▁$ 2 7 . 2 ▁billion . ▁Gu id ant ▁was ▁split ▁between ▁Boston ▁Scient ific ▁and ▁Abb ott ▁Labor ator ies . ▁ ▁Post - mer ger ▁In ▁December ▁ 2 0 0 7 , ▁Boston ▁Scient ific ▁announced ▁it ▁would ▁sell ▁its ▁Fl uid ▁Management ▁and ▁Ven ous ▁Access ▁business es ▁for ▁$ 4 2 5 ▁million ▁to ▁Av ista ▁Capital ▁Part ners . ▁ ▁In ▁April ▁ 2 0 0 8 ▁the ▁company ▁acquired ▁Cry o Cor , ▁Inc . ▁for ▁$ 1 . 3 5 ▁per ▁share , ▁$ 1 7 . 6 ▁million ▁in ▁total